[Federal Register Volume 67, Number 150 (Monday, August 5, 2002)]
[Notices]
[Pages 50650-50651]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-19708]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Bacterial Superantigen Vaccines

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent No. 6,399,332 
entitled ``Bacterial Superantigen Vaccines,'' issued June 4, 2002. 
Foreign rights (PCT/US98/16766) are also available. The United States 
Government, as represented by the Secretary of the Army has rights in 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge

[[Page 50651]]

Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-
5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The present invention relates to genetically 
attenuated super-antigen toxin vaccines altered such that superantigen 
attributes are absent, however the superantigen is effectively 
recognized and an appropriate immune response is produced. The 
attenuated superantigen toxins are shown to protect animals against 
challenge with wild type toxin. Methods of producing and using the 
altered superantigen toxins are described.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-19708 Filed 8-2-02; 8:45 am]
BILLING CODE 3710-08-M